As antibiotic resistance to the drugs used to treat UTIs grows, producing a vaccine to prevent them becomes more crucial. How one team is leading the way.
As Research & Policy Media Relations Manager at the U-M Institute for Healthcare Policy and Innovation (IHPI), Kara Gavin draws on 25 years of experience in communicating about science, medicine and health policy. Her responsibilities include creating compelling stories about discoveries made by the U-M Medical School's biomedical and mental health researchers, the findings and opinions of the 490 healthcare wonks at the U-M IHPI, and the innovative education available at U-M for future doctors and medical scientists.
Hundreds of thousands of hospital patients get a pricey genetic test. But it’s often unnecessary, a team of U-M clinicians says.
A new analysis of public data shows some hospitals are penalized for patients’ readmissions, though they do better at keeping patients alive.
Even when clinicians agree an MRI or CT isn’t needed, referral and patient factors get in the way, a new survey shows.
In 20 years, only 92 gold-standard studies have been done for cardiac arrest, though it happens a staggering 535,000 times annually in the U.S.
The same approach that helps patients manage powerful blood thinners could help expand access to medication-based addiction treatment.